Mind & Mood
Ego dissolution, and why it isn't scary on paper
The most mythologised part of the experience, described in the careful language researchers actually use.
Read the field noteField Notes
The Journal — plain-language pieces translating real psychedelic science. What the research actually says, who's doing it, and why we fund it. No hype, no noise.
Latest field notes
Updated weekly · written by clinicians and the studio
Research Watch
Microdosing: the evidence, minus the hype
Placebo is a powerful thing. We weigh the best-controlled studies on sub-perceptual dosing.
By Dr. Lena Fischer
The Cause
Where the 12% actually goes
An itemised look at the charities we fund, how we vet them, and what the money has paid for so far.
By The Studio
The Craft
One line, unbroken: drawing Spore Print
How a single continuous stroke became the signature of the Cap line — and the idea of connectivity behind it.
By The Studio
The Science
Neuroplasticity, the most over-used word in the field
Everyone says psychedelics rewire the brain. We pin down what that means at the level of a single synapse.
By Dr. Dana Okafor
Mind & Mood
Set and setting isn't woo — it's protocol
The two words that decide whether a session heals or harms — and how clinics operationalise them.
By Dr. Lena Fischer
Research Watch
Phase III, finally: what the latest trial readout means
A landmark depression trial just reported. We read the actual paper so you don't have to — what's solid, what's still open.
By The Studio
The Science
The default-mode network, in plain English.
The brain's idle chatter — the voice that ruminates and builds the story of you — and what happens to it under psilocybin.
By Dr. Dana Okafor
No field notes here yet.
We're still writing this one. Try another topic.
The newsletter
Field Notes, by email.
One considered piece every week or two. Real science, plainly told — and first look at each new drop.
No noise, no selling your data. Unsubscribe anytime.